Controlled-Release Nifedipine Effectively Inhibits Morning Hypertension: A Cross-Over Study with Doxazosin
نویسندگان
چکیده
منابع مشابه
Noise exposure and risk of hypertension: a cross-sectional study
Abstract Background: Previous studies have indicated an unspecific correlation between noise exposure and blood pressure disturbances. Blood pressure disturbances could be caused by the environmental hazards such as noise exposure. The aim of this study is to analyze whether there is a relationship between noise exposure and hypertension. Methods: Atotal sample of 218 workers workin...
متن کاملDoxazosin Suppresses the Morning Increase Blood Pressure and Sympathetic Nervous Act in Patients with Essential Hypertension in ivity
the circadian variation of blood pressure and the power spectrum of R-R intervals using an ambulatory multibiomedical monitoring system (TM2425) in 10 untreated outpatients with essential hypertension. After a 2-wk placebo period (P-period), we administered 1 to 4 mg of doxazosin mesilate to the patients for 2 to 6 wk (T-period). We measured systolic and diastolic blood pressure (SBP, DBP), hea...
متن کاملDoxazosin GITS versus standard doxazosin in mild to moderate hypertension.
BACKGROUND The selective alpha 1-adrenoceptor antagonist doxazosin in both standard formulation and gastrointestinal therapeutic system (GITS) controlled-release formulation is effective for hypertension without having a negative impact on serum lipids. This study was designed to compare the relative efficacy of these two formulations of doxazosin on clinic and ambulatory blood pressure and ser...
متن کاملA crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension.
In a crossover design, control of blood pressure by extended release felodipine was compared with control by prolonged action nifedipine in 21 children with renal hypertension. Compliance with once daily felodipine was higher than with nifedipine, at 95.6 (SEM 2.7)% v 78.9 (6.0)% (p = 0.02). Mean diastolic blood pressure was lower during the day with felodipine than with nifedipine, at 77.6 (2....
متن کاملDialysis-Associated Hypertension Treated with Telmisartan – DiaTel: A Pilot, Placebo-Controlled, Cross-Over, Randomized Trial
UNLABELLED Treatment of hypertension in hemodialysis (HD) patients is characterised by lack of evidence for both the blood pressure (BP) target goal and the recommended drug class to use. Telmisartan, an Angiotensin receptor blocker (ARB) that is metabolised in the liver and not excreted via HD extracorporeal circuit might be particularly suitable for HD patients. We designed and conducted a ra...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
سال: 2007
ISSN: 1882-8272,0388-1601
DOI: 10.3999/jscpt.38.89